APA (7th ed.) Citation

E, N., DA, M., D, D., CJ, G., & B, V. (2025). Three-Year Results of XEN-45 Implantation for Glaucoma Secondary to Fuchs Uveitis Syndrome, Intermediate Uveitis, and Juvenile Idiopathic Arthritis-Related Anterior Uveitis. Ocular immunology and inflammation, 33(3), 463. https://doi.org/10.1080/09273948.2024.2423197

Chicago Style (17th ed.) Citation

E, Nasyrov, Merle DA, Doycheva D, Gassel CJ, and Voykov B. "Three-Year Results of XEN-45 Implantation for Glaucoma Secondary to Fuchs Uveitis Syndrome, Intermediate Uveitis, and Juvenile Idiopathic Arthritis-Related Anterior Uveitis." Ocular Immunology and Inflammation 33, no. 3 (2025): 463. https://doi.org/10.1080/09273948.2024.2423197.

MLA (9th ed.) Citation

E, Nasyrov, et al. "Three-Year Results of XEN-45 Implantation for Glaucoma Secondary to Fuchs Uveitis Syndrome, Intermediate Uveitis, and Juvenile Idiopathic Arthritis-Related Anterior Uveitis." Ocular Immunology and Inflammation, vol. 33, no. 3, 2025, p. 463, https://doi.org/10.1080/09273948.2024.2423197.